Suchergebnisse - "Kashii, Masafumi"

PubPharm (7)

1

An investigation of the differential therapeutic effects of romosozumab on postmenopausal osteoporosis patients with or without rheumatoid arthritis complications : a case-control study

enthalten in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2024

von Ebina, K. | Nagayama, Y. | Kashii, M. | +11

2

Impact of the duration of previous osteoporosis treatment on the effect of romosozumab in patients with postmenopausal osteoporosis

enthalten in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2022

von Ebina, K. | Etani, Y. | Tsuboi, H. | +14

CommentOn: Osteoporos Int. 2022 Jun;33(6):1265-1273. - PMID 35059774

3

Effects of prior osteoporosis treatment on 12-month treatment response of romosozumab in patients with postmenopausal osteoporosis

enthalten in: Joint bone spine | 2021

von Ebina, K. | Tsuboi, H. | Nagayama, Y. | +13

4

Effects of prior osteoporosis treatment on early treatment response of romosozumab in patients with postmenopausal osteoporosis

enthalten in: Bone | 2020

von Ebina, K. | Hirao, M. | Tsuboi, H. | +11

5

Combined effect of teriparatide and an anti-RANKL monoclonal antibody on bone defect regeneration in mice with glucocorticoid-induced osteoporosis

enthalten in: Bone | 2020

von Etani, Y. | Ebina, K. | Hirao, M. | +11

6

The combined effects of teriparatide and anti-RANKL monoclonal antibody on bone defect regeneration in ovariectomized mice

enthalten in: Bone | 2020

von Kitaguchi, K. | Kashii, M. | Ebina, K. | +7

7

Effects of single or combination therapy of teriparatide and anti-RANKL monoclonal antibody on bone defect regeneration in mice

enthalten in: Bone | 2018

von Kitaguchi, K. | Kashii, M. | Ebina, K. | +7

1
[1]